InMed Pharmaceuticals Inc (INM:NASDAQ)

$0.88 -0.01 (-1.12%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 76

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed InMed Pharmaceuticals Inc (INM:NASDAQ) News Sources

India’s weight-loss drugs to get cheaper as semaglutide patent expires

The Economic Times on MSN

external link

Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say

The Economic Times on MSN

external link

Indoco Remedies rises on USFDA approval for Brivaracetam oral solution

Business Standard

external link
INM stock
INM stock price
INM stock price today
INM stock prediction
INM earnings date
INM news
INM price
INM share
INM share price
INM shares
INM ceo
INM premarket
$INM
INM ticker
INM after hours
INM stock
INM stock price
INM stock price today
INM stock prediction
INM earnings date
INM news
INM price
INM share
INM share price
INM shares
INM ceo
INM premarket
$INM
INM ticker
INM after hours

InMed Pharmaceuticals Inc (INM:NASDAQ) FAQs

toggle

What is the current price of InMed Pharmaceuticals Inc (INM:NASDAQ)?

The current price of InMed Pharmaceuticals Inc (INM:NASDAQ) is $0.88.


toggle

InMed Pharmaceuticals Inc (INM:NASDAQ) absolute price change since previous trading day?

The absolute price change of InMed Pharmaceuticals Inc (INM:NASDAQ) since the previous trading day is $-0.01.


toggle

InMed Pharmaceuticals Inc (INM:NASDAQ) percentage price change since previous trading day?

The percentage price change of InMed Pharmaceuticals Inc (INM:NASDAQ) since the previous trading day is -1.12%.


toggle

What is This Week's average sentiment score for InMed Pharmaceuticals Inc (INM:NASDAQ)?

This Week's average sentiment score for InMed Pharmaceuticals Inc (INM:NASDAQ) is 76 out of 100.


toggle

What is This Week's average sentiment for InMed Pharmaceuticals Inc (INM:NASDAQ)?

This Week's sentiment for InMed Pharmaceuticals Inc (INM:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.